Company expands board of directors and makes key leadership promotions to support upcoming late-stage trials of PP405 in androgenetic alopecia Maykin Ho, Ph.D., appointed to Pelage board of directors Nathan Wheeler, MPH, appointed Chief Operating Officer Lisa Sherman promoted to Vice President, Head of Clinical Operations LOS ANGELES–(BUSINESS WIRE)–Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology … [Read more…]

Why closing knowledge gaps matters for patients, healthcare and innovation. VIENNA–(BUSINESS WIRE)–#AOPHealth—Between 27 and 36 million1 people in Europe are living with a rare disease, yet only around six percent currently have access to an approved treatment2. Progress in diagnosis and treatment is often slowed by knowledge gaps, including the lack of clear, reliable, and … [Read more…]

PHILADELPHIA–(BUSINESS WIRE)–Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI), in Denver, CO, that a single intramuscular dose of VRON-0200, its novel, first-in-class, immunotherapy for HBV Functional Cure was able to “spark” and re-awaken durable HBV-specific … [Read more…]

CHELMSFORD, Mass.–(BUSINESS WIRE)–The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers, and retailers of cannabis products in the United States, today announced that the ad hoc group of noteholders of the Company’s 9.25% Senior Secured Notes due December 31, 2028 and … [Read more…]

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter of 2025 after market close on Tuesday, March 3, 2026. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. … [Read more…]

Deal Joins Science’s World-Class BCI Tools with Neurosoft’s Leading Neural Data Platform ALAMEDA, Calif. & GENEVA–(BUSINESS WIRE)–Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft Bioelectronics, a neural data company utilizing ultra-soft interfaces to achieve full-cortical coverage powering a foundation AI model of the brain, have partnered to … [Read more…]

600 creators will walk the red carpet as social commerce surpasses $100 billion WEST HOLLYWOOD, Calif.–(BUSINESS WIRE)–#ExpoWest–Goli Nutrition Inc., in collaboration with TikTok, will host the inaugural Goli Gala on March 3 in Anaheim, California. The awards ceremony will occur on the opening night of Natural Products Expo West, the largest natural and organic products … [Read more…]

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Monday, March 2, 2026, at 4:30 p.m. E.T., to discuss its fourth quarter and full year 2025 financial results. Quanterix will issue a press release regarding its … [Read more…]

HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to present at the upcoming 46th Annual TD Cowen Healthcare Conference in Boston. Pulse Biosciences’ Management is scheduled to present on Wednesday, March 4, 2026, at 1:10 pm … [Read more…]

– First and only all-oral, fixed-duration regimen designed to provide CLL patients with the potential to experience time off treatment – – Approval expands Genentech’s fixed-duration portfolio by providing eligible first-line patients another option alongside the established Venclexta plus Gazyva regimen – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, … [Read more…]